Will Zepatier by Merck Monopolize Hepatitis C Market?

Will Zepatier by Merck Monopolize Hepatitis C Market? In October 2014, Gilead launched Harvoni to cover more market in a single-tablet formulation. With Harvoni's launch, the need for the interferon has been completely eliminated. The miracle drug reduced the treatment … Continue reading